AZITHROMYCIN FOR INJECTION, USP
AURO PHARMA INC
Quick answers
Is there a shortage of AZITHROMYCIN FOR INJECTION, USP in Canada?
No. There is no current shortage of AZITHROMYCIN FOR INJECTION, USP 500MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AZITHROMYCIN FOR INJECTION, USP
HOSPIRA HEALTHCARE ULC
AZITHROMYCIN FOR INJECTION
STERIMAX INC
Other Products
RIVA AZITHROMYCIN
LABORATOIRE RIVA INC.
AVA-AZITHROMYCIN
AVANSTRA INC
AZITHROMYCIN
4513347 CANADA INC.
ACT AZITHROMYCIN
ACTAVIS PHARMA COMPANY
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02465604
Strength
500MG
Dosage Form
Powder For Solution
Route
Intravenous
Active Ingredient
AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE)
See all AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from AURO PHARMA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MG · DIN 02494558
2G · DIN 02462346
500MG · DIN 02462311
1G · DIN 02462338
250MG · DIN 02462303
DIN 02454513
70MG · DIN 02388553
10MG · DIN 02388545
10MG · DIN 02443201
10MG · DIN 02397080
5MG · DIN 02397072
250MG · DIN 02458594